The authors describe how law enforcement deflection programs have been implemented at six U.S. sites and identify key program facilitators and barriers. The authors also conducted outcome analyses at two of the sites.
Clients at publicly-funded mental health clinics support MOUD treatment, signaling a need to expand access and build awareness of MOUDs in these settings.
This report identifies approaches to expanding the Air Force's Task Force True North program, which seeks to provide prevention and treatment programs to airmen in need by embedding health care providers directly into units.
In this study of 2,031 adults with children aged 6 months through 4 years, half indicated they intended to get their child a COVID-19 vaccine at some point, but only one-fifth intended to do so within 3 months of the child's eligibility.
U.S. service members separated from the military for refusing the COVID-19 vaccine were largely separated with a general discharge under honorable conditions. While they may be eligible for health care and disability compensation from the VA, they are not eligible for G.I. Bill benefits. How have they fared as they entered civilian society unvaccinated and with limited benefits?
This weekly recap focuses on understanding the racial wealth gap, why long COVID may threaten the U.S. economy, what prevents people of color from becoming and staying teachers, and more.
Researchers used Medicaid claims during the period 2006–2013 to investigate the relationship between buprenorphine prior authorization requirements and changes in treatment in the years following policy implementation.
Researchers examined IQVIA Longitudinal Prescription Claims data and assessed predictors of buprenorphine discontinuation in the early months of the COVID-19 pandemic (April–July 2020) compared with a pre-pandemic period (April–July 2019).
The number of active prescriptions for the opioid disorder treatment drug buprenorphine remained constant during the first year of the COVID-19 pandemic, but the number of new prescriptions for the treatment was far below what would normally have been expected.
A national survey ( N = 1025) conducted in August 2021 reveals that Americans' belief in misinformation about COVID-19 was negatively associated with vaccine acceptance.
The RAND Corporation is evaluating California's statewide prevention and early intervention programs, which aim to reduce negative outcomes for people experiencing mental illness.
RAND collected, analyzed, and co-interpreted with other Equity-First Vaccination Initiative (EVI) partners both quantitative and qualitative data to promote equity in the COVID-19 response through vaccination.
Using the RAND American Life Panel (ALP), we examine relationships among COVID and influenza vaccination amongst those who historically never, sometimes, or always vaccinate for influenza.
The Equity-First Vaccination Initiative invested $21 million in community-based organizations to reduce racial disparities in vaccination rollout and support strengthening public health systems in the United States over the longer term. The initiative demonstrated a path forward for funders to center equity in their approach to grantmaking.
The authors conduct a review to identify measures, guidelines, and tools that (1) assess social support, the need for caregiver support, and the need for referral to social services and (2) screen for cognitive impairment among high-risk patients.
The findings suggest that the out-of-pocket cost of naloxone has been an increasingly substantial barrier to naloxone access for uninsured patients, a population that constitutes nearly one-fifth of adults with opioid use disorder.
The project will advance understanding of effective financing strategies to support the implementation and sustainment of evidence-based practices for the treatment of adolescent substance use disorders.
This study reports on the results of a qualitative analysis that identified and categorized state medications for opioid use disorder related statutes and regulations in a stratified random sample of 16 states and Washington D.C.
This qualitative study used the ExpertLens online platform to conduct a 3-round modified Delphi process to examine expert consensus on the effectiveness and the ability to implement state-level OUD treatment policies.
